celecoxib and ah 23848
celecoxib has been researched along with ah 23848 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Edwards, RP; Kalinski, P; Muthuswamy, R; Obermajer, N; Odunsi, K | 1 |
Other Studies
1 other study(ies) available for celecoxib and ah 23848
| Article | Year |
|---|---|
PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
Topics: Biphenyl Compounds; CD11b Antigen; Celecoxib; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Monocytes; Myeloid Cells; Ovarian Neoplasms; Prostaglandin Antagonists; Pyrazoles; Receptors, CXCR4; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides; Tumor Cells, Cultured; Tumor Microenvironment; Xanthones | 2011 |